Cancer Home > Testicular Cancer Research
Research studies are currently focused on new ways to treat testicular cancer and on therapies that may improve the quality of life for people during or after treatment. Scientists researching testicular cancer also are studying the use of high-dose chemotherapy with stem cell transplant as a treatment. Clinical trials allow participants to be among the first to benefit from new treatments that have shown promise in earlier research.
Doctors all over the country are conducting testicular cancer research studies in which people volunteer to participate. While some studies are looking for new ways to treat the disease, others are searching for therapies that may improve the quality of life for people during or after testicular cancer treatment.
These research studies are designed to answer important questions and to find out whether new approaches are safe and effective. While research into testicular cancer already has led to many advances, scientists continue to search for more effective methods for treating the disease.
Testicular cancer research scientists are currently studying high-dose chemotherapy with stem cell transplant. This is a treatment that involves the use of high doses of chemotherapy and the replacement of blood-forming cells that are destroyed by the treatment.
In this procedure, stem cells (immature blood cells) are removed from the blood or bone marrow of the person or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the person through an infusion. These reinfused stem cells will then grow and restore the body's blood cells.
People who join research studies on testicular cancer will have the first chance to benefit from treatments that have shown promise in earlier research. Volunteers will also make an important contribution to medical science by helping doctors learn more about this disease. Although research trials may pose some risks, scientists take careful steps to protect participants.